CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-17 | WEISER MICHAEL Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2018-07-17 | MCPEAK MERRILL A Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2018-07-17 | Dukes Iain D. Director | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2018-07-17 | Maynard Ryan D Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2018-07-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,321 | $12.80 | $17K | 333,177 |
| 2018-06-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,321 | $14.55 | $19K | 334,498 |
| 2018-05-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,321 | $14.60 | $19K | 335,819 |
| 2018-04-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,321 | $16.90 | $22K | 337,140 |
| 2018-03-15 | WEISER MICHAEL Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-03-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,321 | $18.15 | $24K | 338,461 |
| 2018-02-09 | Fardis Maria President and CEO | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2018-02-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,525 | $16.50 | $25K | 339,782 |
| 2018-01-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,562 | $8.00 | $12K | 341,307 |
| 2017-12-29 | Vogt Frederick G General Counsel | Grant or award · Stock Option (right to buy) | +37,400 | 37,400 | ||
| 2017-12-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,994 | $8.80 | $18K | 342,869 |
| 2017-11-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,994 | $7.15 | $14K | 344,863 |
| 2017-10-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,993 | $7.75 | $15K | 346,857 |
| 2017-09-08 | Dukes Iain D. Director | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2017-09-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,994 | $6.00 | $12K | 348,850 |
| 2017-08-14 | MORRIS TIMOTHY E Chief Financial Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 |
Page 25 of 31 · 605 trades